• Emerg Med Australas · Aug 2020

    COVID-19 and toxicity from potential treatments: panacea or poison.

    Wong briefly summarises COVID pharmaceutical therapies that are currently in trial, and importantly have received media attention.

    Highlighting that off-label use of these drugs may be important causes of future toxicological presentations to emergency departments, especially for those widely used in the community for other indications (eg. Plaquenil, Kaletra, colchicine...).

    Briefly discussed are:

    • Chloroquine/hydroxychloroquine
    • Azithromycin
    • Kaletra (Lopinavir/ritonavir)
    • Colchicine
    • Ivermectin
    • Tocilizumab
    • Thaildomide
    • Remdesivir
    summary
    • Anselm Wong.
    • Victorian Poisons Information Centre, Austin Toxicology Unit and Emergency Department, Austin Health, Melbourne, Victoria, Australia.
    • Emerg Med Australas. 2020 Aug 1; 32 (4): 697699697-699.

    AbstractSince December 2019, coronavirus disease (COVID-19) has been increasingly spreading from its origin in Wuhan, China to many countries around the world eventuating in morbidity and mortality affecting millions of people. This pandemic has proven to be a challenge given that there is no immediate cure, no vaccine is currently available and medications or treatments being used are still undergoing clinical trials. There have already been examples of self-medication and overdose. Clearly, there is a need to further define the efficacy of treatments used in the management of COVID-19. This evidence needs to be backed by large randomised-controlled clinical trials. In the meantime, there will no doubt be further off-label use of these medications by patients and practitioners and possibly related toxicity.© 2020 Australasian College for Emergency Medicine.

      Pubmed     Free full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

    summary
    1

    Wong briefly summarises COVID pharmaceutical therapies that are currently in trial, and importantly have received media attention.

    Highlighting that off-label use of these drugs may be important causes of future toxicological presentations to emergency departments, especially for those widely used in the community for other indications (eg. Plaquenil, Kaletra, colchicine...).

    Briefly discussed are:

    • Chloroquine/hydroxychloroquine
    • Azithromycin
    • Kaletra (Lopinavir/ritonavir)
    • Colchicine
    • Ivermectin
    • Tocilizumab
    • Thaildomide
    • Remdesivir
    Daniel Jolley  Daniel Jolley
     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.